Analysis of the mechanism of psychotropic action of a 3-hydroxypyridine derivative.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001362:Avoidance Learning / Q000187:drug effects; D001667:Binding, Competitive; D003220:Conflict, Psychological / Q000187:drug effects*; D003975:Diazepam / Q000378:metabolism; D005071:Evoked Potentials / Q000187:drug effects; D000860:Hypoxia / Q000188:drug therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D010847:Picolines / Q000494:pharmacology* / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000494:pharmacology; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism; D012640:Seizures / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D010847:Picolines; D011619:Psychotropic Drugs; D011963:Receptors, GABA-A; D003975:Diazepam; C009820:6-methyl-2-ethyl-3-hydroxypyridine